Prime Medicine, Inc. (PRME) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of$0.28. This compares to a loss of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -14.29$0.36 per share when it actually produced a loss of $0.41, delivering a surprise of -13.89%.Over the last four quarters, the company has ...